Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -27.135% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a O=C(O)c1ccc(N2C(=O)CC(N3C(=O)/C(=C/c4ccc(Cl)cc4)SC3=S)C2=O)cc1
b CCOC(=O)c1cccc(NC(=O)CCc2c(C)nc3ncnn3c2C)c1
Answer: b. CCOC(=O)c1cccc(NC(=O)CCc2c(C)nc3ncnn3c2C)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOC(=O)c1cccc(NC(=O)CCc2c(C)nc3ncnn3c2C)c1
CCOC(=O)c1cccc(NC(=O)CCc2c(C)nc3ncnn3c2C)c1
ethyl 3-[3-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-6-yl)propanoylamino]benzoate